[1
]
From the Lipid Clinic, Endocrinology and Nutrition Service, Institut d'Investigacions
Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain (A.S.-V.,
E.R.); Ciber Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud
Carlos III (ISCIII), Madrid, Spain (A.S.-V., E.-S.R.-M., I.N., R.d.l.T., D.C., V.R.-G.,
M.-C.L.-S., X.P., J.R., M.-Á.M.-G., R.E., E.R.); Department of Internal Medicine,
IDIBAPS, Hospital Clinic, Barcelona, Spain (E.-S.R.-M., R.E.); Diagnostic Imaging
Centre, IDIBAPS, Hospital Clínic, Barcelona, Spain (R.G., I.N.); Human Pharmacology
and Clinical Neurosciences Research Group, Institut de Investigacions Mèdiques Hospital
del Mar, Barcelona, Spain (R.d.l.T.); Department of Preventive Medicine, University
of Valencia, Valencia, Spain (D.C.); Instituto de la Grasa, Consejo Superior de Investigaciones
Cientificas, Sevilla, Spain (V.R.-G.); Department of Nutrition and Food Science, School
of Pharmacy, XaRTA, INSA, University of Barcelona, Barcelona, Spain (M.-C.L.-S.);
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge,
Hospitalet de Llobregat, Barcelona, Spain (X.P.); Department of Cardiology, University
Hospital of Alava, Vitoria, Spain (J.R.); and Department of Preventive Medicine and
Public Health, School of Medicine, University of Navarra-Clínica Universidad de Navarra,
Pamplona, Spain (M.-Á.M.-G.).